tiprankstipranks
Inhibrx Biosciences, Inc. (INBX)
NASDAQ:INBX
US Market
Want to see INBX full AI Analyst Report?

Compare Inhibrx Biosciences Inc (INBX) vs. Competitors

72 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Inhibrx Biosciences Inc
$85.32
$1.59B
-7.83
803.83%
2 Buy
0 Hold
0 Sell
Moderate Buy
Prothena
$10.90
$510.97M
3.99
45.35%
3 Buy
1 Hold
1 Sell
Moderate Buy
CytomX Therapeutics
$4.82
$785.91M
-11.41
80.50%
9 Buy
0 Hold
0 Sell
Strong Buy
Humacyte
$0.71
$206.50M
-1.70
-50.79%
5 Buy
1 Hold
0 Sell
Strong Buy
Monte Rosa Therapeutics
$19.78
$1.53B
-6.06
368.99%
7 Buy
0 Hold
0 Sell
Strong Buy
Candel Therapeutics
$6.37
$642.58M
-8.62
71.62%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INBX
Inhibrx Biosciences Inc
108.64
96.17
771.21%
PRTA
Prothena
9.76
2.36
31.89%
CTMX
CytomX Therapeutics
3.61
1.48
69.48%
HUMA
Humacyte
0.93
-1.30
-58.30%
GLUE
Monte Rosa Therapeutics
18.15
14.04
341.61%
CADL
Candel Therapeutics
8.77
3.07
53.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts